Insulin Pump market in North America is expected to grow at an 8.7% CAGR between 2022 and 2032

According to Future Market Insights’ newly released Insulin Pumps Market analysis report, global sales of the Insulin Pump market in 2021 will be valued at US$ 5 billion. Market growth is projected to be 10.3% from 2022 to 2032, which is significantly higher than historical growth. The absolute dollar opportunity for the Insulin Pump market …

North America is expected to possess 40% market share for Rosai-Dorfman Disease (RDD) Therapeutics market in 2023 | FMI

During the forecast period 2023 to 2033, the Rosai-Dorfman Disease (RDD) Therapeutics market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Rosai-Dorfman Disease (RDD) Therapeutics is expected to rise up to a market valuation of US$ 839.95 Million. The global …

New Innovations opens Prospects for the Cardiogenic Shock Treatment Market, Propelling the Growth of Market at 7% CAGR through 2033 | FMI Study

The global Cardiogenic Shock Treatment Market is experiencing significant growth due to a range of factors, including increased incidence of heart disease, growing adoption of mechanical support devices, and technological advancements in medical devices and therapies. A report published by Future Market Insights predicts that the market will grow at a compound annual growth rate …

EIA Kits To Hold 53% Market Share for Chronic Hepatitis B Virus Testing Market | FMI Study

During the forecast period 2023 to 2033, the Chronic Hepatitis B Virus Testing market is expected to grow at a value of 6.9% CAGR, according to Future Market Insights. By the year 2033, the global market for Chronic Hepatitis B Virus Testing is expected to rise up to a market valuation of US$ 1790 Million. …

Japan accounted for a 4.5% CAGR in the global hospital capacity management solutions market by 2033.

During the forecast period, it is expected that the market for hospital capacity management solutions will expand at a CAGR of 5.1% on average. Because of this, the market has a share of US$ 1.1 billion in 2023 and anticipates US$ 1.9 billion in revenue by 2033. FMI, an ESOMAR-certified market research firm, states that the global hospital …

Automated Suturing Devices Market is projected to secure US$ 3.02 Billion in 2022 and reach US$ 6.2 Billion by 2032

[Report of 257 Pages] The global market for automated suturing devices is expected to reach $3.02 billion in 2022 and $6.2 billion by 2032. The global automated suturing devices market is expected to grow at a 7.46% CAGR between 2022 and 2032. The growing prevalence of chronic disorders, as well as a growing preference for minimally invasive …

Pharmacovigilance Market to US$ 24.32 billion in 2032, at a CAGR of 13.1% from 2022 to 2032

[315 Pages Report]  ESOMAR-certified company Future Market Insights (FMI) has published a report on the global pharmacovigilance market for the forecast period 2021-2031. According to the report, the market is poised to reach new heights, as pharmaceutical companies scramble to introduce new drug candidates for multiple ailments, which will result in an increase in clinical trials. As …

South Korea Hospital Stretchers Market to accumulate US$ 88 Billion by 2032

According to forecasts, the Hospital Stretchers Market in South Korea is projected to reach US$ 88 Million by 2032.  South Korea’s hospital stretcher market is expected to grow at a CAGR of 6.1% during the forecast period. The global hospital stretcher market is experiencing continuous growth and is expected to maintain this trend for the foreseeable …

2009’s Horrors Well and Truly a Part of the Past | Future Market Insights Investigates Europe Market for Swine Vaccine to Uncover Critical Trends

The United Kingdom Swine Vaccine Market is expected to reach US$ 112 million in 2032. A healthy CAGR of 6.1% is anticipated for the market between 2022 and 2032, which is likely to result in an absolute dollar opportunity of US$ 48 million. In a new report, Future Market Insights (FMI) has estimated that the global swine vaccine market was valued at US$ …

Eltrombopag and Romiplostim Therapies Emerging as Effective Second-Line Chronic Immune Thrombocytopenia Treatment | FMI Predicts Korea to Remain a Key Revenue Generation Market

Future Market Insights in its latest report predicts Korea Thrombocytopenia Treatment Market to progress at around 3.5% to 4.0% CAGR between 2023 and 2033. Sales of thrombocytopenia medication in the global market are slated to rise at a CAGR of 5.2% throughout the forecast period (2023 to 2033). Introduction of new treatments and medications for thrombocytopenia in Korea has the potential …